HOME >> MEDICINE >> NEWS
Transdermal patch as effective as intravenous pump for post-op pain control

yl PCTS and 76.9 percent of patients who received IV PCA morphine.

"Early patient discontinuations (25.9 percent fentanyl vs. 25.0 percent morphine) and last pain intensity scores (32.7 fentanyl vs. 31.1 morphine on the visual analog scale) were not different between the 2 treatments. With continued treatment for up to 48 or 72 hours, more than 80 percent of patient assessments in each treatment group were good or excellent. The incidence of opioid-related adverse events was similar between the groups," the researchers write.


'"/>

Contact: Jeffrey Baxt
215-955-5507
JAMA and Archives Journals
16-Mar-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. Study shows patch therapy may be as effective as oral medications
3. Free nicotine patches increase short-term smoking quit rates
4. Testosterone patch will test FDAs decision making
5. Antidepressant may help people stop smoking when used with nicotine patch
6. New ways identified to treat lazy eye in children: Beyond eye patches and daily drops
7. Success of nicotine patches linked to genetic make-up
8. Lesser amount of patching effective for treating lazy eye in children
9. Will stop-smoking patch help slow memory loss?
10. Atropine may be an alternative to patching for treatment of lazy eye in children
11. Oestrogen-replacement therapy from skin patches not associated with venous blood clots

Post Your Comments:
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... in adult allogeneic stem cell manufacturing, research and ... Professor of Medicine and Director of Interventional Cardiology ... to join the Scientific and Medical Advisory Board ... University of Pennsylvania, Dr. Wilensky divides his time ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 This ... around the world will make the pilgrimage to San ... 2nd annual Digital Health Summer Summit produced ... provides a unique forum to showcase the latest digital ... best practices, and network with some of industry’s most ...
(Date:5/20/2013)... May 20, 2013 Adeptia ... and on-premise business process integration solutions, today ... its next-generation integration solution. Version 6.0 ... that seamlessly automates business processes involving data ... meaningful business user interaction for real-time decision-making ...
(Date:5/20/2013)... (HealthDay News) -- Although many hospital intensive care ... to help improve outcomes, new research suggests this ... Since one-third of teaching hospitals in the United ... a nighttime physician in the ICU, the practice ... away from hospitals with fewer resources, the study ...
(Date:5/20/2013)... 2013 In celebration of National Women’s ... accomplishments achieved at The Feinstein Institute for Medical ... Advancing Women in Science and Medicine (AWSM) , ... Scientists, educators, business and community leaders from the ... of women in science. , “Women face unique ...
Breaking Medicine News(10 mins):Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
Cached News: